Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance
The apps are embedded into the Exo Iris transducer, which can be plugged directly into a smartphone, utilized anywhere and without the internet.
Symptom-detected breast cancers more likely to require mastectomy, chemotherapy
New research adds to the “strong evidence” supporting screening guidelines and highlights the importance of women adhering to clinical recommendations.
Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs
POCUS could represent a quick, easy and affordable way to detect signs of insulin resistance before it progresses into diabetes, researchers suggest.
Contrast-enhanced mammography significantly improves early cancer detection
New trial results suggest CEM could enhance breast cancer detection beyond DBT exams when patients are faced with barriers to obtaining an MRI.
Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA
The investigational agent uses 60% less gadolinium without sacrificing image quality, according to recent clinical trial findings.

VIDEO: Gender differences in women with cardiovascular disease and implications for imagers

Erin D. Michos, MD, co-editor in chief of the American Journal of Preventive Cardiology, discusses gender differences in heart disease presentations.

2 imaging orgs to spread ultrasound access around the world and over the long haul

Something like 50 million people in 10 parts of the developing world stand to experience a bounce in quality of healthcare in coming years thanks to a major new aid project co-led by two large nonprofits with expertise in medical imaging.

Preclinical med students quick studies in cardiac POCUS

Briefly trained in point-of-care cardiac ultrasound, 72% of second-year medical students obtained clinical-quality views from a mannequin and 61% made the correct diagnosis in a volunteer simulated patient.

Pediatric TBI study links mild head injuries with behavioral problems in kids

A new analysis revealed that children are at a 15% increased risk of an emotional or behavioral problem if they have experienced a mild TBI.

Specially trained radiographers spot breast cancer at rates comparable to radiologists

Radiographers trained to recognize certain findings on screening mammograms could help address the worldwide shortage of radiologists.

AI for assessing bone fragility gets breakthrough tag

Orthopedic cone-beam CT supplier CurveBeam AI has received the FDA’s breakthrough device designation for software that computes risk of fracture in patients with osteopenia.

Comparison of flurpiridaz F-18 PET, SPECT and angiography of the 60-year-old female patients in the Aurora trial. The SPECT scan appeared normal, but flurpiridaz was shown to be more sensitive and showed the ischemia from two blockages in the right coronary artery. The new radiotracer may help expand cardiac PET. #ASNC

Flurpiridaz data shows promise to expand and enhance cardiac PET

The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) PET radiotracer agent.

New analysis reveals enormous variations in prostate MRI pricing

A total of 37,073 MRI examinations conducted at 552 facilities across the U.S. between January 2010 and March 2020 were included in the analysis.

Medical Imaging

First AI-enabled POCUS app for detecting pleural effusion and atelectasis earns FDA clearance

Symptom-detected breast cancers more likely to require mastectomy, chemotherapy

Shoulder ultrasound effectively detects insulin resistance, even before abnormal labs

Contrast-enhanced mammography significantly improves early cancer detection

Bayer seeks FDA approval for gadoquatrane, its latest low-dose GBCA